TUDOR INVESTMENT CORP ET AL - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 142 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$316,000
-59.0%
32,200
-54.1%
0.01%
-50.0%
Q1 2016$771,000
+24.0%
70,121
+3.8%
0.02%
+17.6%
Q4 2015$622,000
+4.9%
67,578
-20.9%
0.02%
-15.0%
Q3 2015$593,000
+113.3%
85,471
+201.9%
0.02%
+150.0%
Q2 2015$278,000
-10.6%
28,310
-19.2%
0.01%
-20.0%
Q1 2015$311,000
-13.9%
35,055
-14.9%
0.01%
-23.1%
Q4 2014$361,000
+24.5%
41,174
-2.1%
0.01%
+30.0%
Q3 2014$290,000
+61.1%
42,053
+17.8%
0.01%
+11.1%
Q4 2013$180,000
+26.8%
35,700
+27.0%
0.01%
+50.0%
Q3 2013$142,000
+10.9%
28,100
+8.9%
0.01%
-40.0%
Q2 2013$128,00025,8000.01%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Sensato Investors LLC 1,552,482$13,755,0002.96%
Nantahala Capital Management 1,522,625$13,490,0002.24%
GLOBEFLEX CAPITAL L P 150,138$1,330,0000.25%
Ativo Capital Management LLC 71,563$634,0000.25%
MCKINLEY CAPITAL MANAGEMENT LLC 543,110$4,812,0000.19%
RFG Advisory, LLC 24,700$208,0000.16%
GSA CAPITAL PARTNERS LLP 345,833$3,064,0000.12%
Spark Investment Management LLC 95,900$849,0000.12%
Numeric Investors LLC 1,002,814$8,885,0000.11%
ClariVest Asset Management LLC 384,222$3,404,0000.10%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders